BofA warns Fed risks policy mistake with early rate cuts
Cathie Wood’s ARK ETF published their daily trades for Monday, March 24th, 2025, revealing a series of strategic moves that saw the fund add to its positions in key tech and biotech companies, while also trimming holdings in several others.
The most significant acquisition of the day was in Baidu Inc (NASDAQ:BIDU), with ARK purchasing a total of 129,451 shares across its ARKQ and ARKW ETFs, representing a total dollar value of $12,238,297. This purchase underscores ARK’s confidence in the Chinese technology giant, known for its internet services and AI products.
Beam Therapeutics Inc (NASDAQ:BEAM) also saw a notable addition, with ARK buying 143,163 shares worth $3,335,697. This move comes as ARK continues to invest in the promising field of precision genetic medicine, with BEAM being a recurrent focus in recent trades.
Iridium Communications Inc (NASDAQ:IRDM) was another beneficiary of ARK’s buying activity. A total of 140,602 shares were acquired, distributed among ARKK, ARKQ, and ARKX (NYSE:ARKX) ETFs, amounting to $3,887,645. ARK’s consistent investment in IRDM reflects a growing trend in the fund’s portfolio towards satellite communication technologies.
On the sell side, ARK divested a substantial number of shares in Roblox Corp (NYSE:RBLX), with 78,406 shares sold from its ARKW ETF for a total of $4,795,310. This sale represents a significant shift in ARK’s holdings of the online gaming platform, which has been a part of its portfolio for some time.
Another major sale involved Ansys Inc (NASDAQ:ANSS), a leader in simulation software. ARK sold a total of 15,281 shares across ARKQ and ARKX ETFs, totaling $4,954,100. The divestment could signal a strategic repositioning away from the engineering software provider.
UiPath Inc (NYSE:PATH) also saw a reduction in ARK’s holdings, with 243,086 shares sold between the ARKK and ARKQ ETFs, valued at $2,627,759. This continues a pattern of ARK offloading shares in the robotic process automation company.
Smaller trades included purchases of Intuitive Machines Inc (NASDAQ:LUNR), Pacific Biosciences of California Inc (NASDAQ:PACB), and Recursion Pharmaceuticals Inc (NASDAQ:RXRX), as well as sales of Roku Inc (NASDAQ:ROKU) and Repare Therapeutics Inc (NASDAQ:RPTX).
Investors following ARK’s trading activity may note the fund’s ongoing strategy of investing in innovative companies with disruptive potential while adjusting its portfolio in response to market conditions and company performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.